Brighton, Massachusetts
The Robert R. Linton MD Professor of Vascular and Endovascular Surgery
Harvard Medical School
Chief, Division of Vascular and Endovascular Surgery
St. Elizabeth Medical Center
SCHEDULE FOR VEITHsymposium™
Tuesday, November 14, 2017
Presentation Moderator
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADS, THORACIC AORTIC DISEASE, TAAAS AND RELATED TOPICS
Presenter
SESSION 8: MORE ABOUT TBADS, CONTROVERSIES ABOUT TIMING, INDICATIONS AND VALUE OF TEVAR TREATMENT FOR PATIENTS WITH UNCOMPLICATED TBADS
Do We Need Another Randomized Controlled Trial (RCT) Comparing TEVAR And Good Medical Treatment Alone With Good Medical Treatment For Uncomplicated TBADs
5:20 PM - 5:25 PM

View Slides in PDF
Wednesday, November 15, 2017
Presenter
SESSION 38: ISSUES WITH TRIALS; RCTS; GUIDELINES; STANDARDS; REGISTRIES; QUALITY INITIATIVES; THE SVS AND THE JVS
What Is The SVS/VQI/FDA TEVAR For Aortic Dissection Registry: What New And Useful Information Will It Provide
5:24 PM - 5:29 PM

View Slides in PDF
 
previous next